These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19353723)

  • 41. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
    Kelesidis I; Mazurek J; Khullar P; Saeed W; Vittorio T; Zolty R
    Congest Heart Fail; 2012; 18(3):158-64. PubMed ID: 22497779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective evaluation of nesiritide in the treatment of pediatric heart failure.
    Jefferies JL; Denfield SW; Price JF; Dreyer WJ; McMahon CJ; Grenier MA; Kim JJ; Dimas VV; Clunie SK; Moffett BS; Chang AC; Wann TI; Smith EO; Towbin JA
    Pediatr Cardiol; 2006; 27(4):402-7. PubMed ID: 16830089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.
    Gong B; Wu Z; Li Z
    BMJ Open; 2016 Jan; 6(1):e008545. PubMed ID: 26739721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 47. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
    Yancy CW; Singh A
    Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.
    Greene SJ; Hernandez AF; Sun JL; Butler J; Armstrong PW; Ezekowitz JA; Zannad F; Ferreira JP; Coles A; Metra M; Voors AA; Califf RM; O'Connor CM; Mentz RJ
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004783. PubMed ID: 30354576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension.
    Kelesidis I; Mazurek JA; Saeed W; Chaudhari R; Velankar P; Zolty R
    Congest Heart Fail; 2012; 18(1):18-24. PubMed ID: 22277173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
    Ng TM; Ackerbauer KA; Hyderi AF; Hshieh S; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):79-85. PubMed ID: 21536855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nesiritide: a new therapy for the treatment of heart failure.
    Maisel AS
    Cardiovasc Toxicol; 2003; 3(1):37-42. PubMed ID: 12668889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure.
    Butler J; Emerman C; Peacock WF; Mathur VS; Young JB;
    Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.
    Tang WHW; Dupont M; Hernandez AF; Voors AA; Hsu AP; Felker GM; Butler J; Metra M; Anker SD; Troughton RW; Gottlieb SS; McMurray JJ; Armstrong PW; Massie BM; Califf RM; O'Connor CM; Starling RC
    JACC Heart Fail; 2015 Jan; 3(1):40-49. PubMed ID: 25453534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.
    Pleister AP; Baliga RR; Haas GJ
    Curr Heart Fail Rep; 2011 Sep; 8(3):226-32. PubMed ID: 21695395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure.
    Bartone C; Saghir S; Menon SG; Brosmer J; Kereiakes DJ; Mazur W; Chung ES
    Congest Heart Fail; 2008; 14(6):298-301. PubMed ID: 19076851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction.
    Zhao Q; Wu TG; Lin Y; Li B; Luo JY; Wang LX
    Heart Vessels; 2010 Mar; 25(2):97-103. PubMed ID: 20339970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
    Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT
    J Card Fail; 2011 Mar; 17(3):181-7. PubMed ID: 21362524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.